In last trading session, Eterna Therapeutics Inc (NASDAQ:ERNA) saw 0.18 million shares changing hands with its beta currently measuring 4.25. Company’s recent per share price level of $0.44 trading at -$0.03 or -6.00% at ring of the bell on the day assigns it a market valuation of $22.61M. That closing price of ERNA’s stock is at a discount of -495.45% from its 52-week high price of $2.62 and is indicating a discount of -4.55% from its 52-week low price of $0.46. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.38 million shares which gives us an average trading volume of 90.68K if we extend that period to 3-months.

Eterna Therapeutics Inc (NASDAQ:ERNA) trade information

Upright in the red during last session for losing -6.00%, in the last five days ERNA remained trading in the red while hitting it’s week-highest on Thursday, 11/21/24 when the stock touched $0.44 price level, adding 31.68% to its value on the day. Eterna Therapeutics Inc’s shares saw a change of -75.49% in year-to-date performance and have moved -28.42% in past 5-day. Eterna Therapeutics Inc (NASDAQ:ERNA) showed a performance of -60.00% in past 30-days. Number of shares sold short was 44458.0 shares which calculate 1.07 days to cover the short interests.

Eterna Therapeutics Inc (ERNA) estimates and forecasts

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0.06% during past 5 years.

Eterna Therapeutics Inc (NASDAQ:ERNA)’s Major holders

Insiders are in possession of 336.35% of company’s total shares while institution are holding 11.00 percent of that, with stock having share float percentage of -4.65%. Investors also watch the number of corporate investors in a company very closely, which is 11.00% institutions for Eterna Therapeutics Inc that are currently holding shares of the company.